ANIX
Anixa Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$84.04M
P/E Ratio
—
EPS
$-0.30
Beta
0.60
52W High
$5.46
52W Low
$2.32
50-Day MA
$2.79
200-Day MA
$3.31
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Anixa Biosciences Inc
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is headquartered in San Jose, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-13.10M |
| Operating Margin | 0.00% |
| Return on Equity | -72.00% |
| Return on Assets | -41.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.43 |
| Price-to-Book | 5.76 |
| Price-to-Sales (TTM) | 377.78 |
| EV/Revenue | 274.8 |
| EV/EBITDA | -8.76 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $34.02M |
| Float | $32.19M |
| % Insiders | 5.30% |
| % Institutions | 15.15% |
Historical Volatility
HV 10-Day
55.95%
HV 20-Day
45.14%
HV 30-Day
42.99%
HV 60-Day
50.57%
HV Rank
6.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($10.00 target)
1
Strong Buy2
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026